The Point of Care Lipid Test Market size was estimated USD 41.33 billion in 2023 and is expected to reach USD 69.96 billion by 2031 at a CAGR of 6.8% during the forecast period of 2024-2031.
Point of care lipid test are medical tests that help in the diagnosis of a condition in the human body at a precise moment. The point of care testing help to provide real-time results in minutes. As a result, a point of care (POC) lipid test is conducted to evaluate the lipid's activity in the cells. When cholesterol levels rise, the body's lipid function is disrupted, leading to significant ailments such as heart attack and coronary artery disease.
Get More Information on Point of Care Lipid Test Market - Request Sample Report
DRIVERS
A point-of-care (PoC) cholesterol test is gaining interest in the treatment of liver and kidney disorders.
Rising cases of chronic diseases such as liver and kidney disorders, as well as diabetes, are likely to drive the global point of care (PoC) lipid test market during the forecast period. Cardiovascular disease (CVD) is the major cause of death in chronic renal disease patients. One of the most prominent pathophysiological causes for CVD in CKD patients is the widespread and probably enhanced production of atherosclerotic plaques due to hyperlipidemia, uremic toxins, inflammation, and endothelial dysfunction. Chronic kidney disease (CKD) affects more than one out of every seven adults in the United States, or over 37 million people, according to the US Department of Health and Human Services. These are the variables that drive market expansion.
RESTRAINT
In some regions, there are no reimbursement policies for POC lipid tests.
In emerging economies, product availability is limited.
Issues with quality control linked with POC lipid testing devices.
OPPORTUNITY
Partnerships between diagnostic businesses and healthcare providers for efficient point-of-care testing.
Creation of novel POC lipid test technology with expanded capabilities.
Increasing need for technological advances
Rising need for technical developments that improve speed, accuracy, and usability, as well as rising market penetration rates for technologies such as self-testing handheld devices, are likely to fuel demand. Polymer Technology Systems Inc., for example, developed the CardioChek Plus analyzer in 2013, an upgraded version of their point-of-care multi-analyte device. Sedentary and unhealthy lifestyle choices are likely to supply manufacturers with a growing customer base.
CHALLENGES
High price
The rising cost of point-of-care (POC) cholesterol diagnostics will restrain market expansion. It has an additional cost of $2500.00. Furthermore, a lack of lab services in rural areas, particularly in developing countries, would stymie market growth. The scarcity of trained personnel in these domains would further hinder market growth prospects.
The war has significantly increased psychological pain and distress. According to health care professionals around the country, the most common request right now is for help with sleeplessness, anxiety, mourning, and psychological distress. WHO has increased staff and repurposed infrastructure, particularly the logistics system, in response to changing health demands in Ukraine. This has allowed for the delivery of over 543 metric tonnes of medical supplies and equipment to the country, which are being distributed mostly in the east, south, and northern oblasts where the need is highest. Among the materials sent are trauma surgical supplies, ambulances, Ukrainian-made ventilators that can continue to work even when power is down, electric generators, and oxygen equipment, including the construction of oxygen plants.
IMPACT OF ONGOING RECESSION
Three years after the pandemic immobilized the world, its aftermath continues to send the world into a frenzy as the recession siren becomes louder with each passing day. Several businesses, particularly scientific research, are concerned about the current recession warning. The pandemic has reduced the number of new programs and shifted financing to virology and vaccine development. This has a negative impact on research outside of the field of virology and life sciences in general. With several countries in recession, economists forecast a slight recession this year as economic uncertainty grows. Despite the promise of a surge in research funding in 2023, the scientific community is concerned about the consequences of the recession on research financing.
By Product
Glucose monitoring
Strips
Meters
Lancets
Cardiometabolic testing products
Cardiac marker testing products
hsTnl
BNP
D-dimer
CK-MB
Myoglobin
Others
Blood gas/electrolytes testing products
HBAIC testing products
Infectious disease testing products
Influenza testing products
HIV testing products
Hepatitis C testing products
Sexually transmitted disease (STD) testing products
Healthcare-associated infection (HAl) testing products
Respiratory infection testing products
Tropical disease testing products
Others
Coagulation testing products
PT/INR testing products
Activated clotting time (ACT/APTT) testing products
Pregnancy and fertility testing products
Pregnancy testing products
Fertility testing products
Tumor/cancer marker testing products
Cholesterol testing products
Hematology testing products
Drug-of-abuse (DoA) testing products
Fecal occult testing products
Urinalysis testing products
Others
In 2023, glucose monitoring segment is expected to held the highest market share during the forecast period due to the growing popularity of portable, highly convenient, and cost-effective POC glucose tests. Point-of-care blood glucose (BG) testing has grown in popularity over central laboratory testing due to its quick response time. Furthermore, blood glucose POCT eliminates post-analytical and pre-analytical factors that may have an impact on test analysis, such as transportation, multiple user handling, order verification, and delayed reporting, resulting in improved test analysis.
By Technology
Lateral flow assays
Dipsticks
Microfluidics
Molecular diagnostics
Immunoassays
Agglutination assays
Flow-through
Solid phase
Biosensors
In 2023, the Biosensors segment is expected to dominate the market growth during the forecast period. Biosensor technology has grown in popularity due to its capacity to give speedy, accurate, and on-site diagnostic information. As a result, healthcare providers may make quick and informed decisions, leading to better patient outcomes. Intricon, a manufacturer of smart miniaturized electronics-powered medical devices, created the new Biosensors Centre of Excellence in January 2023 to consolidate its biosensor device knowledge into a vertically connected organization for offering biosensor devices to the medical business.
By Prescription
OTC testing
Prescription-based testing
By Application
Cardio metabolic testing
Infectious disease testing
Nephrology testing
Drug-of-abuse testing
Blood glucose testing
Pregnancy testing
Cancer biomarker testing
Others
In 2023, the nephrology testing segment is expected to dominate the market growth during the forecast period owing to the increased frequency of renal failures and other related illnesses. According to a CDC analysis published in 2023, more than one out of every seven persons, or 35.6 million Americans, suffer from chronic renal disease. POCT in nephrology has resulted in faster and more reliable results, allowing for early interventions and tailored treatment plans. Furthermore, the portability and convenience of use of point-of-care testing equipment allows testing in remote and resource-constrained areas, improving patient outcomes and saving healthcare costs.
By End-use
Hospitals
Diagnostic centers
Research laboratories
Home-care settings
Others
North America held a significant market share in 2023 due to Rising R&D investments and brisk private funding for healthcare infrastructure development are propelling the industry forward. Furthermore, various market competitors are concentrating on developing testing solutions that will provide early results, thereby improving the regional market picture. In May 2023, Sensible Diagnostics, a Los Angeles-based startup, produced a tiny, low-cost sample-to-answer system that can do PCR in 10 minutes, along with economical test cartridges, with the initial focus on infectious disease testing at the point of care.
Asia-Pacific is witness to expand fastest CAGR rate during the forecast period owing to the region's aging population and the increased need for point-of-care testing devices for patients. Furthermore, the region's rising chronic illness burden, combined with the increased emphasis of significant corporations in emerging markets such as China, Japan, and others, is increasing demand for and adoption of point-of-care (PoC) cholesterol test devices.
Get Customized Report as per Your Business Requirement - Request For Customized Report
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Vital Biosciences, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories. Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, Medtronic Plc, Meridian Bioscience, Nova Biomedical, OraSure Technologies, Siemens Healthineers AG, and BioLytical Laboratories Inc., and Others.
In July 2023, Vital Biosciences introduced VitalOne, a new point-of-care lab testing technology that allows clinicians to conduct tests, diagnose patients, and treat them all in a single visit.
In January 2022, in regions where the CE Mark is accepted, Roche launched the Cobas pulse system, which combines professional blood glucose control with mobile digital medical capabilities to improve patient care.
| Report Attributes | Details |
| Market Size in 2023 | US$ 41.33 Billion |
| Market Size by 2031 | US$ 69.96 Billion |
| CAGR | CAGR of 6.8 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Glucose monitoring, Cardiometabolic testing products, Infectious disease testing products, Coagulation testing products, Pregnancy and fertility testing products, Tumor/cancer marker testing products, Cholesterol testing products, Hematology testing products, Drug-of-abuse (DoA) testing products, Fecal occult testing products, Urinalysis testing products, Others) • By Technology (Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-through, Solid phase, Biosensors) • By Prescription (OTC testing, Prescription-based testing) • By Application (Cardio metabolic testing, Infectious disease testing, Nephrology testing, Drug-of-abuse testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing, Others) • By End User (Hospitals, Diagnostic centers, Research laboratories, Home-care settings, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Vital Biosciences, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories. Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, Medtronic Plc, Meridian Bioscience, Nova Biomedical, OraSure Technologies, Siemens Healthineers AG, and BioLytical Laboratories Inc. |
| Key Drivers | • A point-of-care (PoC) cholesterol test is gaining interest in the treatment of liver and kidney disorders. |
| Market Restrain | • In some regions, there are no reimbursement policies for POC lipid tests. • In emerging economies, product availability is limited. • Issues with quality control linked with POC lipid testing devices. |
Ans: Point of Care Lipid Test Market is anticipated to expand by 6.8% from 2023 to 2030.
Ans: The expected growth rate of Care Lipid Test Market is USD 69.96 billion by 2031.
Ans: Point of Care Lipid Test Market size was valued at USD 41.33 billion in 2023.
Ans: North America is dominating the market of Point of Care Lipid Test Market.
Ans: Partnerships between diagnostic businesses and healthcare providers for efficient point-of-care testing.
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Point of Care Lipid Test Market Segmentation, By Product
9.1 Introduction
9.3 Glucose monitoring
9.3.1 Strips
9.3.2 Meters
9.3.3 Lancets
9.4 Cardiometabolic testing products
9.4.1 Cardiac marker testing products
9.4.1.1 hsTnl
9.4.1.2 BNP
9.4.1.3 D-dimer
9.4.1.4 CK-MB
9.4.1.5 Myoglobin
9.4.1.6 Others
9.4.2 Blood gas/electrolytes testing products
9.4.3 HBAIC testing products
9.5 Infectious disease testing products
9.5.1 Influenza testing products
9.5.2 HIV testing products
9.5.3 Hepatitis C testing products
9.5.4 Sexually transmitted disease (STD) testing products
9.5.5 Healthcare-associated infection (HAl) testing products
9.5.6 Respiratory infection testing products
9.5.7 Tropical disease testing products
9.5.8 Others
9.6 Coagulation testing products
9.6.1PT/INR testing products
9.6.2 Activated clotting time (ACT/APTT) testing products
9.7 Pregnancy and fertility testing products
9.7.1 Pregnancy testing products
9.7.2 Fertility testing products
9.8 Tumor/cancer marker testing products
9.9 Cholesterol testing products
9.10 Hematology testing products
9.11 Drug-of-abuse (DoA) testing products
9.12 Fecal occult testing products
9.13 Urinalysis testing products
9.14 Others
10. Point of Care Lipid Test Market Segmentation, By Technology
10.1 Introduction
10.2 Trend Analysis
10.4 Dipsticks
10.5 Microfluidics
10.6 Molecular diagnostics
10.7 Immunoassays
10.8 Agglutination assays
10.9 Flow-through
10.10 Solid phase
10.11 Biosensors
11. Point of Care Lipid Test Market Segmentation, By Prescription
11.1 Introduction
11.2 Trend Analysis
11.4 Prescription-based testing
12. Point of Care Lipid Test Market Segmentation, By Application
12.1 Introduction
12.2 Trend Analysis
12.4 Infectious disease testing
12.5 Nephrology testing
12.6 Drug-of-abuse testing
12.7 Blood glucose testing
12.8 Pregnancy testing
12.9 Cancer biomarker testing
13. Point of Care Lipid Test Market Segmentation, By End- use
13.1 Introduction
13.3 Hospitals
13.4 Diagnostic centers
13.5 Research laboratories
13.6 Home-care settings
13.7 Others
14. Regional Analysis
14.1 Introduction
14.2 North America
14.2.1 Trend Analysis
14.2.2 North America Point of Care Lipid Test Market By Country
14.2.3 North America Point of Care Lipid Test Market By Product
14.2.4 North America Point of Care Lipid Test Market By Technology
14.2.5 North America Point of Care Lipid Test Market By Prescription
14.2.6 North America Point of Care Lipid Test Market, By Application
14.2.7 North America Point of Care Lipid Test Market, By End- use
14.2.8 USA
14.2.8.1 USA Point of Care Lipid Test Market By Product
14.2.8.2 USA Point of Care Lipid Test Market By Technology
14.2.8.3 USA Point of Care Lipid Test Market By Prescription
14.2.8.4 USA Point of Care Lipid Test Market, By Application
14.2.8.5 USA Point of Care Lipid Test Market, By End- use
14.2.9 Canada
14.2.9.1 Canada Point of Care Lipid Test Market By Product
14.2.9.2 Canada Point of Care Lipid Test Market By Technology
14.2.9.3 Canada Point of Care Lipid Test Market By Prescription
14.2.9.4 Canada Point of Care Lipid Test Market, By Application
14.2.9.5 Canada Point of Care Lipid Test Market, By End- use
14.2.10 Mexico
14.2.10.1 Mexico Point of Care Lipid Test Market By Product
14.2.10.2 Mexico Point of Care Lipid Test Market By Technology
14.2.10.3 Mexico Point of Care Lipid Test Market By Prescription
14.2.10.4 Mexico Point of Care Lipid Test Market, By Application
14.2.10.5 Mexico Point of Care Lipid Test Market, By End- use
14.3 Europe
14.3.1 Trend Analysis
14.3.2 Eastern Europe
14.3.2.1 Eastern Europe Point of Care Lipid Test Market By Country
14.3.2.2 Eastern Europe Point of Care Lipid Test Market By Product
14.3.2.3 Eastern Europe Point of Care Lipid Test Market By Technology
14.3.2.4 Eastern Europe Point of Care Lipid Test Market By Prescription
14.3.2.5 Eastern Europe Point of Care Lipid Test Market By Application
14.3.2.6 Eastern Europe Point of Care Lipid Test Market, By End- use
14.3.2.7 Poland
14.3.2.7.1 Poland Point of Care Lipid Test Market By Product
14.3.2.7.2 Poland Point of Care Lipid Test Market By Technology
14.3.2.7.3 Poland Point of Care Lipid Test Market By Prescription
14.3.2.7.4 Poland Point of Care Lipid Test Market By Application
14.3.2.7.5 Poland Point of Care Lipid Test Market, By End- use
14.3.2.8 Romania
14.3.2.8.1 Romania Point of Care Lipid Test Market By Product
14.3.2.8.2 Romania Point of Care Lipid Test Market By Technology
14.3.2.8.3 Romania Point of Care Lipid Test Market By Prescription
14.3.2.8.4 Romania Point of Care Lipid Test Market By Application
14.3.2.8.5 Romania Point of Care Lipid Test Market, By End- use
14.3.2.9 Hungary
14.3.2.9.1 Hungary Point of Care Lipid Test Market By Product
14.3.2.9.2 Hungary Point of Care Lipid Test Market By Technology
14.3.2.9.3 Hungary Point of Care Lipid Test Market By Prescription
14.3.2.9.4 Hungary Point of Care Lipid Test Market By Application
14.3.2.9.5 Hungary Point of Care Lipid Test Market, By End- use
14.3.2.10 Turkey
14.3.2.10.1 Turkey Point of Care Lipid Test Market By Product
14.3.2.10.2 Turkey Point of Care Lipid Test Market By Technology
14.3.2.10.3 Turkey Point of Care Lipid Test Market By Prescription
14.3.2.10.4 Turkey Point of Care Lipid Test Market By Application
14.3.2.10.5 Turkey Point of Care Lipid Test Market, By End- use
14.3.2.11 Rest of Eastern Europe
14.3.2.11.1 Rest of Eastern Europe Point of Care Lipid Test Market By Product
14.3.2.11.2 Rest of Eastern Europe Point of Care Lipid Test Market By Technology
14.3.2.11.3 Rest of Eastern Europe Point of Care Lipid Test Market By Prescription
14.3.2.11.4 Rest of Eastern Europe Point of Care Lipid Test Market By Application
14.3.2.11.5 Rest of Eastern Europe Point of Care Lipid Test Market, By End- use
14.3.3 Western Europe
14.3.3.1 Western Europe Point of Care Lipid Test Market By Country
14.3.3.2 Western Europe Point of Care Lipid Test Market By Product
14.3.3.3 Western Europe Point of Care Lipid Test Market By Technology
14.3.3.4 Western Europe Point of Care Lipid Test Market By Prescription
14.3.3.5 Western Europe Point of Care Lipid Test Market By Application
14.3.3.6 Western Europe Point of Care Lipid Test Market, By End- use
14.3.3.7 Germany
14.3.3.7.1 Germany Point of Care Lipid Test Market By Product
14.3.3.7.2 Germany Point of Care Lipid Test Market By Technology
14.3.3.7.3 Germany Point of Care Lipid Test Market By Prescription
14.3.3.7.4 Germany Point of Care Lipid Test Market By Application
14.3.3.7.5 Germany Point of Care Lipid Test Market, By End- use
14.3.3.8 France
14.3.3.8.1 France Point of Care Lipid Test Market By Product
14.3.3.8.2 France Point of Care Lipid Test Market By Technology
14.3.3.8.3 France Point of Care Lipid Test Market By Prescription
14.3.3.8.4 France Point of Care Lipid Test Market By Application
14.3.3.8.5 France Point of Care Lipid Test Market, By End- use
14.3.3.9 UK
14.3.3.9.1 UK Point of Care Lipid Test Market By Product
14.3.3.9.2 UK Point of Care Lipid Test Market By Technology
14.3.3.9.3 UK Point of Care Lipid Test Market By Prescription
14.3.3.9.4 UK Point of Care Lipid Test Market By Application
14.3.3.9.5 UK Point of Care Lipid Test Market, By End- use
14.3.3.10 Italy
14.3.3.10.1 Italy Point of Care Lipid Test Market By Product
14.3.3.10.2 Italy Point of Care Lipid Test Market By Technology
14.3.3.10.3 Italy Point of Care Lipid Test Market By Prescription
14.3.3.10.4 Italy Point of Care Lipid Test Market By Application
14.3.3.10.5 Italy Point of Care Lipid Test Market, By End- use
14.3.3.11 Spain
14.3.3.11.1 Spain Point of Care Lipid Test Market By Product
14.3.3.11.2 Spain Point of Care Lipid Test Market By Technology
14.3.3.11.3 Spain Point of Care Lipid Test Market By Prescription
14.3.3.11.4 Spain Point of Care Lipid Test Market By Application
14.3.3.11.5 Spain Point of Care Lipid Test Market, By End- use
14.3.3.12 Netherlands
14.3.3.12.1 Netherlands Point of Care Lipid Test Market By Product
14.3.3.12.2 Netherlands Point of Care Lipid Test Market By Technology
14.3.3.12.3 Netherlands Point of Care Lipid Test Market By Prescription
14.3.3.12.4 Netherlands Point of Care Lipid Test Market By Application
14.3.3.12.5 Netherlands Point of Care Lipid Test Market, By End- use
14.3.3.13 Switzerland
14.3.3.13.1 Switzerland Point of Care Lipid Test Market By Product
14.3.3.13.2 Switzerland Point of Care Lipid Test Market By Technology
14.3.3.13.3 Switzerland Point of Care Lipid Test Market By Prescription
14.3.3.13.4 Switzerland Point of Care Lipid Test Market By Application
14.3.3.13.5 Switzerland Point of Care Lipid Test Market, By End- use
14.3.3.14 Austria
14.3.3.14.1 Austria Point of Care Lipid Test Market By Product
14.3.3.14.2 Austria Point of Care Lipid Test Market By Technology
14.3.3.14.3 Austria Point of Care Lipid Test Market By Prescription
14.3.3.14.4 Austria Point of Care Lipid Test Market By Application
14.3.3.14.5 Austria Point of Care Lipid Test Market, By End- use
14.3.3.15 Rest of Western Europe
14.3.3.15.1 Rest of Western Europe Point of Care Lipid Test Market By Product
14.3.3.15.2 Rest of Western Europe Point of Care Lipid Test Market By Technology
14.3.3.15.3 Rest of Western Europe Point of Care Lipid Test Market By Prescription
14.3.3.15.4 Rest of Western Europe Point of Care Lipid Test Market By Application
14.3.3.15.5 Rest of Western Europe Point of Care Lipid Test Market, By End- use
14.4 Asia-Pacific
14.4.1 Trend Analysis
14.4.2 Asia-Pacific Point of Care Lipid Test Market By country
14.4.3 Asia-Pacific Point of Care Lipid Test Market By Product
14.4.4 Asia-Pacific Point of Care Lipid Test Market By Technology
14.4.5 Asia-Pacific Point of Care Lipid Test Market By Prescription
14.4.6 Asia-Pacific Point of Care Lipid Test Market By Application
14.4.7 Asia-Pacific Point of Care Lipid Test Market, By End- use
14.4.8 China
14.4.8.1 China Point of Care Lipid Test Market By Product
14.4.8.2 China Point of Care Lipid Test Market By Technology
14.4.8.3 China Point of Care Lipid Test Market By Prescription
14.4.8.4 China Point of Care Lipid Test Market By Application
14.4.8.5 China Point of Care Lipid Test Market, By End- use
14.4.9 India
14.4.9.1 India Point of Care Lipid Test Market By Product
14.4.9.2 India Point of Care Lipid Test Market By Technology
14.4.9.3 India Point of Care Lipid Test Market By Prescription
14.4.9.4 India Point of Care Lipid Test Market By Application
14.4.9.5 India Point of Care Lipid Test Market, By End- use
14.4.10 Japan
14.4.10.1 Japan Point of Care Lipid Test Market By Product
14.4.10.2 Japan Point of Care Lipid Test Market By Technology
14.4.10.3 Japan Point of Care Lipid Test Market By Prescription
14.4.10.4 Japan Point of Care Lipid Test Market By Application
14.4.10.5 Japan Point of Care Lipid Test Market, By End- use
14.4.11 South Korea
14.4.11.1 South Korea Point of Care Lipid Test Market By Product
14.4.11.2 South Korea Point of Care Lipid Test Market By Technology
14.4.11.3 South Korea Point of Care Lipid Test Market By Prescription
14.4.11.4 South Korea Point of Care Lipid Test Market By Application
14.4.11.5 South Korea Point of Care Lipid Test Market, By End- use
14.4.12 Vietnam
14.4.12.1 Vietnam Point of Care Lipid Test Market By Product
14.4.12.2 Vietnam Point of Care Lipid Test Market By Technology
14.4.12.3 Vietnam Point of Care Lipid Test Market By Prescription
14.4.12.4 Vietnam Point of Care Lipid Test Market By Application
14.4.12.5 Vietnam Point of Care Lipid Test Market, By End- use
14.4.13 Singapore
14.4.13.1 Singapore Point of Care Lipid Test Market By Product
14.4.13.2 Singapore Point of Care Lipid Test Market By Technology
14.4.13.3 Singapore Point of Care Lipid Test Market By Prescription
14.4.13.4 Singapore Point of Care Lipid Test Market By Application
14.4.13.5 Singapore Point of Care Lipid Test Market, By End- use
14.4.14 Australia
14.4.14.1 Australia Point of Care Lipid Test Market By Product
14.4.14.2 Australia Point of Care Lipid Test Market By Technology
14.4.14.3 Australia Point of Care Lipid Test Market By Prescription
14.4.14.4 Australia Point of Care Lipid Test Market By Application
14.4.14.5 Australia Point of Care Lipid Test Market, By End- use
14.4.15 Rest of Asia-Pacific
14.4.15.1 Rest of Asia-Pacific Point of Care Lipid Test Market By Product
14.4.15.2 Rest of Asia-Pacific Point of Care Lipid Test Market By Technology
14.4.15.3 Rest of Asia-Pacific Point of Care Lipid Test Market By Prescription
14.4.15.4 Rest of Asia-Pacific Point of Care Lipid Test Market By Application
14.4.15.5 Rest of Asia-Pacific Point of Care Lipid Test Market, By End- use
14.5 Middle East & Africa
14.5.1 Trend Analysis
14.5.2 Middle East
14.5.2.1 Middle East Point of Care Lipid Test Market By Country
14.5.2.2 Middle East Point of Care Lipid Test Market By Product
14.5.2.3 Middle East Point of Care Lipid Test Market By Technology
14.5.2.4 Middle East Point of Care Lipid Test Market By Prescription
14.5.2.5 Middle East Point of Care Lipid Test Market By Application
14.5.2.6 Middle East Point of Care Lipid Test Market, By End- use
14.5.2.7 UAE
14.5.2.7.1 UAE Point of Care Lipid Test Market By Product
14.5.2.7.2 UAE Point of Care Lipid Test Market By Technology
14.5.2.7.3 UAE Point of Care Lipid Test Market By Prescription
14.5.2.7.4 UAE Point of Care Lipid Test Market By Application
14.5.2.7.5 UAE Point of Care Lipid Test Market, By End- use
14.5.2.8 Egypt
14.5.2.8.1 Egypt Point of Care Lipid Test Market By Product
14.5.2.8.2 Egypt Point of Care Lipid Test Market By Technology
14.5.2.8.3 Egypt Point of Care Lipid Test Market By Prescription
14.5.2.8.4 Egypt Point of Care Lipid Test Market By Application
14.5.2.8.5 Egypt Point of Care Lipid Test Market, By End- use
14.5.2.9 Saudi Arabia
14.5.2.9.1 Saudi Arabia Point of Care Lipid Test Market By Product
14.5.2.9.2 Saudi Arabia Point of Care Lipid Test Market By Technology
14.5.2.9.3 Saudi Arabia Point of Care Lipid Test Market By Prescription
14.5.2.9.4 Saudi Arabia Point of Care Lipid Test Market By Application
14.5.2.9.5 Saudi Arabia Point of Care Lipid Test Market, By End- use
14.5.2.10 Qatar
14.5.2.10.1 Qatar Point of Care Lipid Test Market By Product
14.5.2.10.2 Qatar Point of Care Lipid Test Market By Technology
14.5.2.10.3 Qatar Point of Care Lipid Test Market By Prescription
14.5.2.10.4 Qatar Point of Care Lipid Test Market By Application
14.5.2.10.5 Qatar Point of Care Lipid Test Market, By End- use
14.5.2.11 Rest of Middle East
14.5.2.11.1 Rest of Middle East Point of Care Lipid Test Market By Product
14.5.2.11.2 Rest of Middle East Point of Care Lipid Test Market By Technology
14.5.2.11.3 Rest of Middle East Point of Care Lipid Test Market By Prescription
14.5.2.11.4 Rest of Middle East Point of Care Lipid Test Market By Application
14.5.2.11.5 Rest of Middle East Point of Care Lipid Test Market, By End- use
14.5.3 Africa
14.5.3.1 Africa Point of Care Lipid Test Market By Country
14.5.3.2 Africa Point of Care Lipid Test Market By Product
14.5.3.3 Africa Point of Care Lipid Test Market By Technology
14.5.3.4 Africa Point of Care Lipid Test Market By Prescription
14.5.3.5 Africa Point of Care Lipid Test Market By Application
14.5.3.6 Africa Point of Care Lipid Test Market, By End- use
14.5.3.7 Nigeria
14.5.3.7.1 Nigeria Point of Care Lipid Test Market By Product
14.5.3.7.2 Nigeria Point of Care Lipid Test Market By Technology
14.5.3.7.3 Nigeria Point of Care Lipid Test Market By Prescription
14.5.3.7.4 Nigeria Point of Care Lipid Test Market By Application
14.5.3.7.5 Nigeria Point of Care Lipid Test Market, By End- use
14.5.3.8 South Africa
14.5.3.8.1 South Africa Point of Care Lipid Test Market By Product
14.5.3.8.2 South Africa Point of Care Lipid Test Market By Technology
14.5.3.8.3 South Africa Point of Care Lipid Test Market By Prescription
14.5.3.8.4 South Africa Point of Care Lipid Test Market By Application
14.5.3.8.5 South Africa Point of Care Lipid Test Market, By End- use
14.5.3.9 Rest of Africa
14.5.3.9.1 Rest of Africa Point of Care Lipid Test Market By Product
14.5.3.9.2 Rest of Africa Point of Care Lipid Test Market By Technology
14.5.3.9.3 Rest of Africa Point of Care Lipid Test Market By Prescription
14.5.3.9.4 Rest of Africa Point of Care Lipid Test Market By Application
14.5.3.9.5 Rest of Africa Point of Care Lipid Test Market, By End- use
14.6 Latin America
14.6.1 Trend Analysis
14.6.2 Latin America Point of Care Lipid Test Market By country
14.6.3 Latin America Point of Care Lipid Test Market By Product
14.6.4 Latin America Point of Care Lipid Test Market By Technology
14.6.5 Latin America Point of Care Lipid Test Market By Prescription
14.6.6 Latin America Point of Care Lipid Test Market By Application
14.6.7 Latin America Point of Care Lipid Test Market, By End- use
14.6.8 Brazil
14.6.8.1 Brazil Point of Care Lipid Test Market By Product
14.6.8.2 Brazil Point of Care Lipid Test Market By Technology
14.6.8.3 Brazil Point of Care Lipid Test Market By Prescription
14.6.8.4 Brazil Point of Care Lipid Test Market By Application
14.6.8.5 Brazil Point of Care Lipid Test Market, By End- use
14.6.9 Argentina
14.6.9.1 Argentina Point of Care Lipid Test Market By Product
14.6.9.2 Argentina Point of Care Lipid Test Market By Technology
14.6.9.3 Argentina Point of Care Lipid Test Market By Prescription
14.6.9.4 Argentina Point of Care Lipid Test Market By Application
14.6.9.5 Argentina Point of Care Lipid Test Market, By End- use
14.6.10 Colombia
14.6.10.1 Colombia Point of Care Lipid Test Market By Product
14.6.10.2 Colombia Point of Care Lipid Test Market By Technology
14.6.10.3 Colombia Point of Care Lipid Test Market By Prescription
14.6.10.4 Colombia Point of Care Lipid Test Market By Application
14.6.10.5 Colombia Point of Care Lipid Test Market, By End- use
14.6.11 Rest of Latin America
14.6.11.1 Rest of Latin America Point of Care Lipid Test Market By Product
14.6.11.2 Rest of Latin America Point of Care Lipid Test Market By Technology
14.6.11.3 Rest of Latin America Point of Care Lipid Test Market By Prescription
14.6.11.4 Rest of Latin America Point of Care Lipid Test Market By Application
14.6.11.5 Rest of Latin America Point of Care Lipid Test Market, By End- use
15. Company Profiles
15.1 Vital Biosciences
15.1.1 Company Overview
15.1.2 Financial
15.1.3 Products/ Services Offered
15.1.4 SWOT Analysis
15.1.5 The SNS View
15.2 Becton
15.2.1 Company Overview
15.2.2 Financial
15.2.3 Products/ Services Offered
15.2.4 SWOT Analysis
15.2.5 The SNS View
15.3 Dickinson and Company
15.3.1 Company Overview
15.3.2 Financial
15.3.3 Products/ Services Offered
15.3.4 SWOT Analysis
15.3.5 The SNS View
15.4 Abbott Laboratories
15.4.1 Company Overview
15.4.2 Financial
15.4.3 Products/ Services Offered
15.4.4 SWOT Analysis
15.4.5 The SNS View
15.5 F. Hoffmann-La Roche
15.5.1 Company Overview
15.5.2 Financial
15.5.3 Products/ Services Offered
15.5.4 SWOT Analysis
15.5.5 The SNS View
15.6 ACON Laboratories, Inc
15.6.1 Company Overview
15.6.2 Financial
15.6.3 Products/ Services Offered
15.6.4 SWOT Analysis
15.6.5 The SNS View
15.7 BioMerieux SA
15.7.1 Company Overview
15.7.2 Financial
15.7.3 Products/ Services Offered
15.7.4 SWOT Analysis
15.7.5 The SNS View
15.8 Bio-Rad Laboratories. Inc
15.8.1 Company Overview
15.8.2 Financial
15.8.3 Products/ Services Offered
15.8.4 SWOT Analysis
15.8.5 The SNS View
15.9 HemoCue AB (Danaher Corporation)
15.9.1 Company Overview
15.9.2 Financial
15.9.3 Products/ Services Offered
15.9.4 SWOT Analysis
15.9.5 The SNS View
15.10 Dexcom, Inc
15.10.1 Company Overview
15.10.2 Financial
15.10.3 Products/ Services Offered
15.10.4 SWOT Analysis
15.10.5 The SNS View
16. Competitive Landscape
16.1 Competitive Benchmarking
16.2 Market Share Analysis
16.3 Recent Developments
16.3.1 Industry News
16.3.2 Company News
16.3.3 Mergers & Acquisitions
17. Use Case and Best Practices
18. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Medical Terminology Software Market Size was valued at USD 1239.76 million in 2022, and is expected to reach USD 5547 million by 2030, and grow at a CAGR of 20.6% over the forecast period 2023-2030.
The Antiperspirants and Deodorants Market Size was valued at USD 29.83 billion in 2023 and is expected to reach USD 44.95 billion by 2031 and grow at a CAGR of 5.31% over the forecast period 2024-2031.
The Breast Cancer Therapeutics Market size was valued at USD 30.22 billion in 2022 and is expected to reach at USD 79.77 billion by 2030, and grow at a CAGR of 12.9% over the forecast period of 2023-2030.
The Dental Bone Grafts and Substitutes Market was valued at USD 820.06 million in 2022, and it is predicted to reach 1.97 billion in 2030 at a CAGR of 11.2 % from 2023 to 2030.
The Clinical Alarm Management Market Size was valued at USD 1405 million in 2022 and is expected to reach USD 9942 million by 2030, and grow at a CAGR of 27.7% over the forecast period 2023-2030.
The Medical Aesthetics Market size was valued at USD 13.5 billion and is estimated to be USD 32.49 billion and grow at a compound annual growth rate of approx. CAGR of 11.6% for the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
